存活心肌判断中存在的问题及其原因

杨斌; 李殿富

存活心肌判断中存在的问题及其原因

杨斌 , 李殿富

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 1: (21-23)

引用本文:

Citation:

存活心肌判断中存在的问题及其原因

杨斌¹,
李殿富²

1. 210019 南京, 东方航空公司卫生处;
2. 210019 南京, 南京医科大学第一附属医院核心脏病学研究室
基金项目:
江苏省卫生厅重点项目(H200509)
中图分类号: R817.4

The problems and the causes in viable myocardial detection

YANG Bin¹,
LI Dian-fu²

1. Department of Health Care, Air Oriental of China, Nanjing 210029, China;
2. Department of Cardiology, The First Afilliated Hospital of Nanjing Medical University, Nanjing 210029, China
CLC number: R817.4

摘要: 存活心肌的判断有重要的临床意义。但目前常用的几项存活心肌检测技术的阳性预测值和特异性仍然偏低,其原因可能与冠脉搭桥术后自身冠脉或桥血管的通畅性、心肌功能恢复的评估时间、研究随访期间的心肌缺血和(或)损伤、血运重建术前的心室重构程度、心内膜下心肌瘢痕形成等因素有关。目前在存活心肌判断方面仍存在着一些尚待解决的问题。
- 心肌 /
- 冠心病 /
- 敏感性 /
- 特异性
Abstract: Viable myocardial detection is very important in clinical practice. But the positive predictive value and specificities of all imagining modalities available are still relatively lower, and the causes may relative to the smooth of native or bridge coronary arteries after operation, the time to assess the function of viable myocardium, myocardial ischemia or damage after operation, the severity of left ventricular modification before revascularization and subendocardiac muscle scarring formation. The problems of viabile myocardial detection were still discussed here.
- Myocardium /
- Coronary artery disease /
- Sensitivity /
- Specificity
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Gibbons R J,Abrams J,Chatterjee K,et al.ACC/AHA 2002 guideline update for the management of patients with chronic stable angina.Circulation,2003,107(1):149-158.
[2]	Klocke FJ,Baird MG,Lorell BH,et al.ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging.Circulation,2003,108(11):1404-1418.
[3]	Berman DS,Hayes SW,Shaw LJ,et al.Recent advances in myocardial perfusion imaging.Curr Probl Cardiol,2001,26(1):1-140.
[4]	Vanovershelde Jean LJ,Holly TA,Di Carli MF,et al.Viability.In:Zaret BL eds.Clinical Nuclear Cardiology.3th ed.Philadelphea:Elsevier Mosby,2005.493-535.
[5]	Allman KC,Shaw LJ,Hachamovitch R,et al.Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:A meta-analysis.J Am Coll Cardiol,2002,39(7):1151-1158.
[6]	Bax JJ,Poldermans D,Elhendy A,et al.Sensitivity,specificity and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium.Curr Pro Cardiol,2001,26(2):141-186.
[7]	Cornel JH,Bax JJ,Elhendy A,et al.Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium.J Nucl Cardiol,1999,6(4):383-388.
[8]	Vanoverschelde JL,Depre C,Gerber BL,et al.Time course of functional recovery after coronary bypass surgery in patients with chronic left ventricular ischemic dysfunction.Am J Cardiol,2000,85(12):1432-1439.
[9]	Leoncini M,Sciagra R,Bellandi F,et al.Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy.J Nucl Cardiol,2002,9(4):402-406.
[10]	Cornel JH,Bax JJ,Elhendy A,et al.Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease:implications of time course of recovery on diagnostic accuracy.J Am Coll Cardiol,1998,31(5):1002-1010.
[11]	Schwarz ER,Schoendube FA,Kostin S,et al.Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revasclarization.J Am Coll Cardiol,1998,31(5):1018-1026.
[12]	Gerber BL,Melin JA,Bol A,et al.Nitrogen-13-ammonia and oxygen-15-water estimates of absolute muocardial perfusion in left ventricular ischemic dysfunction.J Nucl Med,1998,39(10):1655-1662.
[13]	Afridi I,Qureshi U,Kppelen HA,et al.Serial changes in response of hibernating myocardium to inotropic stimuation after revascularization:a dobutamine echocardiographic study.J Am Coll Cardiol,1997,30(5):1233-1240.
[14]	Kasama S,Toyama T,Kumakura H,et al.Low-dose dobutamine stress ^99mTc tetrofosmin quantitative gated SPECT performed during the acute phase of myocardial infarction predicts subsequent myocardial viability and detects stunned myocardium.Nucl Med Commun,2003,24(2):167-174.
[15]	Leoncini M,Marcucci G,Sciagra,et al.Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress.Am J Cardiol,2001,87(12):1346-1350.

[1]	李胜亭 , 刘秀杰 . 心肌显像估测冠心病预后的价值. 国际放射医学核医学杂志, 1996, 20(1): 4-8.
[2]	李殿富 . 核素心肌显像在冠心病处理决策中的合理应用及其原理. 国际放射医学核医学杂志, 2004, 28(2): 56-59.
[3]	李殿富 . 慢性稳定型冠心病的核素心肌灌注显像临床应用进展. 国际放射医学核医学杂志, 2004, 28(3): 97-100.
[4]	郭小闪 , 靳春荣 , 武志芳 , 武萍 , 李莉 , 陈伟强 , 李思进 . 瑞加诺生负荷心肌灌注显像诊断冠心病的初步临床研究. 国际放射医学核医学杂志, 2020, 44(10): 634-640. doi: 10.3760/cma.j.cn121381-202003048-00088
[5]	张建萍 , 刘雪辉 , 于泓煦 , 刘娜 , 沈慧 , 陈兵 . 心肌灌注显像引导下行PCI治疗的Graves甲亢合并冠心病一例. 国际放射医学核医学杂志, 2019, 43(6): 589-592. doi: 10.3760/cma.j.issn.1673-4114.2019.06.016
[6]	孙璐冰 , 阮翘 . 心肌灌注显像联合冠状动脉钙化积分诊断冠心病的价值及最新进展. 国际放射医学核医学杂志, 2017, 41(2): 143-149. doi: 10.3760/cma.j.issn.1673-4114.2017.02.012
[7]	彭琨 , 陈卫强 , 李剑明 . 冠状动脉血流储备分数、心肌血流储备和微循环阻力指数在冠心病患者中的临床应用价值. 国际放射医学核医学杂志, 2019, 43(5): 462-467. doi: 10.3760/cma.j.issn.1673-4114.2019.05.014
[8]	张科 , 谭红霞 , 宋波 . ⁹⁹Tc^m-MIBI心肌灌注显像对行PCI术的冠心病患者中的近期效果的评估作用. 国际放射医学核医学杂志, 2019, 43(5): 422-426. doi: 10.3760/cma.j.issn.1673-4114.2019.05.007
[9]	陈宁琳 , 鲍逸民 , 杨永青 . 血浆ATⅡ、NPY、IGF-1和hs-CRP水平测定在评估冠心病患者严重程度中的应用价值. 国际放射医学核医学杂志, 2014, 38(3): 167-170. doi: 10.3760/cma.j.issn.1673-4114.2014.03.007
[10]	郑丹栅 , 兰晓莉 , 覃春霞 . 门控心肌灌注显像相位分析及其临床应用进展. 国际放射医学核医学杂志, 2021, 45(7): 443-448. doi: 10.3760/cma.j.cn121381-202006012-00060

点击查看大图

计量

文章访问数: 1067
HTML全文浏览量: 68
PDF下载量: 2

存活心肌判断中存在的问题及其原因

杨斌¹
李殿富²

1. 210019 南京, 东方航空公司卫生处;
2. 210019 南京, 南京医科大学第一附属医院核心脏病学研究室

收稿日期: 2006-01-02

基金项目: 江苏省卫生厅重点项目(H200509)

关键词:

心肌 /
冠心病 /
敏感性 /
特异性

摘要: 存活心肌的判断有重要的临床意义。但目前常用的几项存活心肌检测技术的阳性预测值和特异性仍然偏低,其原因可能与冠脉搭桥术后自身冠脉或桥血管的通畅性、心肌功能恢复的评估时间、研究随访期间的心肌缺血和(或)损伤、血运重建术前的心室重构程度、心内膜下心肌瘢痕形成等因素有关。目前在存活心肌判断方面仍存在着一些尚待解决的问题。